On October 31, 2024, the European Commission (the Commission) delivered its long-awaited decision in the Teva Copaxone case (which was published on April 8, 2025). Teva, a global pharmaceutical company, was fined EUR 462.6...more
4/17/2025
/ Abuse of Dominance ,
Antitrust Violations ,
Drug Pricing ,
EU ,
European Commission ,
Generic Drugs ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Teva Pharmaceuticals
The US antitrust regulators continued to aggressively challenge transactions and associated Hart-Scott-Rodino (HSR) violations during the third quarter of 2024. The Federal Trade Commission (FTC) litigated two merger...more
11/1/2024
/ Acquisitions ,
Antitrust Division ,
Competition Authorities ,
Department of Justice (DOJ) ,
Enforcement Actions ,
EU ,
EUMR ,
European Commission ,
Federal Trade Commission (FTC) ,
Filing Requirements ,
Hart-Scott-Rodino Act ,
Mergers ,
Pre-Merger Filing Requirements ,
Regulatory Agenda ,
Regulatory Requirements ,
Reporting Requirements ,
UK ,
UK Competition and Markets Authority (CMA) ,
United States
On October 24, 2024, the European Court of Justice (ECJ) confirmed the annulment by the General Court (GC) of the European Commission’s (EC) decision to impose a EUR 1.06 billion fine on Intel for the abuse of a dominant...more
In a spectacular turn, on September 3, 2024, the Court of Justice (CJEU), constituted as the grand chamber, overturned the ruling of the General Court (GC) and annulled the decision made by the Commission to accept requests...more
9/3/2024
/ Court of Justice of the European Union (CJEU) ,
Digital Markets Strategy ,
EFTA ,
EU ,
EUMR ,
European Commission ,
Legal Costs ,
Member State ,
Merger Controls ,
New Regulations ,
Treaty on the Functioning of the European Union (TFEU)
On July 22, 2024, the European Commission (EC) accepted commitments proposed by Vifor Pharmaceuticals to address disparagement concerns under Article 102 TFEU. This is the EC’s first pure disparagement case and its second...more
8/21/2024
/ Competition ,
Disparagement ,
EU ,
European Commission ,
Financial Conduct Authority (FCA) ,
Investigations ,
Patents ,
Pharmaceutical Industry ,
Teva Pharmaceuticals ,
Treaty on the Functioning of the European Union (TFEU) ,
UK ,
UK Competition and Markets Authority (CMA)
UNITED STATES -
New Merger Guidelines Deployed -
The 2023 Merger Guidelines are a non-binding statement that provides clarity on aspects of federal agencies’ deliberations and enforcement practices undertaken in...more
5/3/2024
/ Acquisitions ,
Artificial Intelligence ,
Department of Justice (DOJ) ,
Emerging Technologies ,
EU ,
Federal Trade Commission (FTC) ,
Foreign Investment ,
Healthcare ,
Horizontal Merger Guidelines ,
Merger Controls ,
Mergers ,
Private Equity ,
UK ,
Vertical Mergers
マクダーモット・インターナショナル・セミナーは、おかげさまで皆様よりご好評をいただき、11回目となるセミナーを東京で開催することが決定いたしました。
本セミナーでは、オースティン、ブリュッセル、ロンドン、ミュンヘン、パリ、サンフランシスコ、ワシントンD.C.の各オフィスの、ビジネス法務の第一線で活躍する経験豊富な弁護士が、日本の企業や法律事務所の皆様に向けて、米国・欧州における法律および実務の重要トピックスに関する最新動向をご提供いたします...more
1/8/2024
/ Antitrust Provisions ,
Artificial Intelligence ,
Best Practices ,
CFIUS ,
Competition ,
Continuing Legal Education ,
Cross-Border Transactions ,
Cybersecurity ,
Data Privacy ,
European Commission ,
Events ,
Foreign Direct Investment ,
Foreign Investment ,
Intellectual Property Protection ,
National Security ,
Supply Chain ,
UK Competition and Markets Authority (CMA)